Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications.
about
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraineTreating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.Selection and preference for botulinum toxins in the management of photoaging and facial lines: patient and physician considerations.Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses.Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasmDuration of action of abobotulinumtoxina and onabotulinumtoxina: a randomized, double-blind study using a contralateral frontalis modelPilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache.Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines.Diffusion of botulinum toxinsRimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study.Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.GDNF overexpression fails to provoke muscle recovery from botulinum toxin poisoning: a preliminary study.Neuromodulator threading: revisiting an approach to neurotoxin delivery.Dynamic Model of Applied Facial Anatomy with Emphasis on Teaching of Botulinum Toxin A.
P2860
Q33572495-377B1F44-459A-4A58-9D90-1DAFBEE1CCF3Q33574491-1C2A63D9-9498-4E5A-BF5B-A151AF504028Q33698934-5C928B5F-6AA1-4E6F-8C8F-0F8EA36A58D0Q34443530-6EF80ED0-AB55-4085-829B-353F32986A76Q34771461-81B39FBA-16BE-410C-A105-864BC6D610BBQ35050218-490DE5F5-0C1C-427A-B6DE-EC9760089BCBQ35220461-0EED87DF-C183-447D-AD3A-276962700452Q35732524-C3B24634-9277-4D71-8E85-6F5FD7EB23B4Q36694302-FAE155A0-19C0-44D4-9BC6-1FA859BDFF28Q38084574-1D1A1AC0-ECF7-46BD-BD86-6CFDB457B4FFQ38457792-1450E993-BD62-4430-AADD-48D8FA2C0E86Q39207459-73B0842D-D5C6-4A3A-9B63-D8ABF2F7B37EQ39369774-39EA4A13-C488-4101-BBDA-FF47365BB7E2Q41835912-ED353F55-AD60-4199-8945-42796DCB6010Q47257142-70D9BBA3-BA8C-489B-8B89-F19008337A77
P2860
Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Diffusion characteristics of b ...... ance in cosmetic applications.
@ast
Diffusion characteristics of b ...... ance in cosmetic applications.
@en
Diffusion characteristics of b ...... ance in cosmetic applications.
@nl
type
label
Diffusion characteristics of b ...... ance in cosmetic applications.
@ast
Diffusion characteristics of b ...... ance in cosmetic applications.
@en
Diffusion characteristics of b ...... ance in cosmetic applications.
@nl
prefLabel
Diffusion characteristics of b ...... ance in cosmetic applications.
@ast
Diffusion characteristics of b ...... ance in cosmetic applications.
@en
Diffusion characteristics of b ...... ance in cosmetic applications.
@nl
P2860
P1476
Diffusion characteristics of b ...... ance in cosmetic applications.
@en
P2093
Ada Trindade de Almeida
Koenraad De Boulle
P2860
P356
10.1080/17429590701523794
P478
P577
2007-01-01T00:00:00Z